Literature DB >> 2147410

Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes.

C V Clevenger1, A L Sillman, M B Prystowsky.   

Abstract

The nuclear translocation of PRL is demonstrated at the immunofluorescence and electron microscopic (EM) levels in interleukin-2 (IL2)-stimulated cloned T-cells and concanavalin A-stimulated splenocytes. This translocation occurs 2-10 h after IL2 stimulation, and is reversed by the addition of anti-PRL antiserum into the extracellular culture medium. The nuclear localization of PRL in IL2 stimulated T-cells was confirmed by postembedding immunogold EM. The nuclear uptake of PRL after IL2 stimulation was further documented by EM studies using PRL-colloidal gold conjugates. These studies suggest that the intranuclear PRL is translocated from the extracellular medium via an endosomal/lysosomal pathway over a period of several hours. Finally, the requirement for PRL no later than 6 h after IL2 stimulation is demonstrated through the reversible inhibition of T-cell growth with anti-PRL antiserum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147410     DOI: 10.1210/endo-127-6-3151

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 2.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

3.  Potential Cancer Prevention and Treatment by Silencing the Killer Cell Immunoglobulin-like Receptor Gene in Natural Killer Cells Derived from Induced Pluripotent Stem Cells.

Authors:  Yunlong Qin; Christina Hutson; Xianfu Wu; Jingyao Xu; Darin Carroll
Journal:  Enliven J Stem Cell Res Regen Med       Date:  2016-07-06

Review 4.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

5.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer.

Authors:  Michael A Rycyzyn; Charles V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 7.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

8.  Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.

Authors:  I Leav; F B Merk; K F Lee; M Loda; M Mandoki; J E McNeal; S M Ho
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

9.  Activation of the prolactin receptor gene by promoter insertion in a Moloney murine leukemia virus-induced rat thymoma.

Authors:  C S Barker; S E Bear; T Keler; N G Copeland; D J Gilbert; N A Jenkins; R S Yeung; P N Tsichlis
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.

Authors:  Nathalie Planque
Journal:  Cell Commun Signal       Date:  2006-10-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.